{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:24:35Z","timestamp":1783607075813,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 06\/23"],"award-info":[{"award-number":["RC 06\/23"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02180-6","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T16:22:47Z","timestamp":1779034967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and quality of life outcomes in children and adolescents with type 1 diabetes using different insulin therapy types: a cross-sectional observational study"],"prefix":"10.1186","volume":"18","author":[{"given":"Gianluca","family":"Tornese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Robino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Mozzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Aldegheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Candia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Tamaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Morosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Chianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalia","family":"Catamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"issue":"1","key":"2180_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/mi14010151","volume":"14","author":"SM Rodrigues Oliveira","year":"2023","unstructured":"Rodrigues Oliveira SM, Rebocho A, Ahmadpour E, et al. Type 1 Diabetes Mellitus: a review on advances and challenges in creating insulin producing devices. Micromachines (Basel). 2023;14(1):151. https:\/\/doi.org\/10.3390\/mi14010151.","journal-title":"Micromachines (Basel)"},{"issue":"14","key":"2180_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977\u201386. https:\/\/doi.org\/10.1056\/NEJM199309303291401.","journal-title":"N Engl J Med"},{"issue":"1","key":"2180_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan DM, DCCCT\/EDIC Research Group. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37(1):9\u201316. https:\/\/doi.org\/10.2337\/dc13-2112.","journal-title":"Diabetes Care"},{"issue":"5","key":"2180_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","volume":"39","author":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabtes Interventions and Complications (EDIC) Study Research Group","year":"2016","unstructured":"Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabtes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686\u201393. https:\/\/doi.org\/10.2337\/dc15-1990.","journal-title":"Diabetes Care"},{"issue":"8","key":"2180_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/dme.12676","volume":"32","author":"JA McKnight","year":"2015","unstructured":"McKnight JA, Wild SH, Lamb MJE, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036\u201350. https:\/\/doi.org\/10.1111\/dme.12676.","journal-title":"Diabet Med"},{"issue":"8","key":"2180_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/pedi.12754","volume":"19","author":"M-A Burckhardt","year":"2018","unstructured":"Burckhardt M-A, Smith GJ, Cooper MN, et al. Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes. Pediatr Diabetes. 2018;19(8):1459\u201366. https:\/\/doi.org\/10.1111\/pedi.12754.","journal-title":"Pediatr Diabetes"},{"key":"2180_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1089\/dia.2016.0288","volume":"18","author":"A Sharifi","year":"2016","unstructured":"Sharifi A, De Bock MI, Jayawardene D, et al. Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technol Ther. 2016;18:772\u201383. https:\/\/doi.org\/10.1089\/dia.2016.0288.","journal-title":"Diabetes Technol Ther"},{"key":"2180_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet. 2018;392:1321\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(18)31947-0.","journal-title":"Lancet"},{"key":"2180_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s41745-022-00348-3","volume":"28","author":"AM Almurashi","year":"2023","unstructured":"Almurashi AM, Rodriguez E, Garg SK. Emerging diabetes technologies: continuous glucose monitors\/artificial pancreases. J Indian Inst Sci. 2023;28:1\u201326. https:\/\/doi.org\/10.1007\/s41745-022-00348-3.","journal-title":"J Indian Inst Sci"},{"key":"2180_CR10","doi-asserted-by":"publisher","first-page":"604028","DOI":"10.3389\/fendo.2021.604028","volume":"12","author":"S Hu","year":"2021","unstructured":"Hu S, Yang H, Chen Z, et al. Clinical outcome and cost-effectiveness analysis of CSII versus MDI in children and adolescent with type 1 diabetes mellitus in a public health care system of China. Front Endocrinol (Lausanne). 2021;12:604028. https:\/\/doi.org\/10.3389\/fendo.2021.604028.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2180_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4274\/jcrpe.0053","volume":"10","author":"Y Qin","year":"2018","unstructured":"Qin Y, Yang L-H, Huang X-L, et al. Efficacy and safety of continuous subcutaneous insulin infusion vs. multiple daily injections on type 1 diabetes children: a meta-analysis of randomized control trials. J Clin Res Pediatr Endocrinol. 2018;10(4):316\u201323. https:\/\/doi.org\/10.4274\/jcrpe.0053.","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"2180_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2022.0421","volume":"25","author":"G Garg Sk, Grunberger","year":"2023","unstructured":"Garg Sk, Grunberger G, Weinstock R, et al. Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. Diabetes Technol Ther. 2023;25(1):1\u201312. https:\/\/doi.org\/10.1089\/dia.2022.0421.","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2180_CR13","doi-asserted-by":"publisher","first-page":"302433","DOI":"10.2337\/dc20-1447","volume":"43","author":"SA McAuley","year":"2020","unstructured":"McAuley SA, Lee MH, Paldus B, et al. Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care. 2020;43(12):302433. https:\/\/doi.org\/10.2337\/dc20-1447.","journal-title":"Diabetes Care"},{"issue":"6","key":"2180_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1159\/000543034","volume":"97","author":"T Biester","year":"2024","unstructured":"Biester T, Berget C, Boughton C, et al. International Society for Pediatric and Adolescent Diabetes clinical practice consensus guidelines 2024: Diabetes technologies \u2013 insulin delivery. Horm Res Paediatr. 2024;97(6):636\u201362. https:\/\/doi.org\/10.1159\/000543034.","journal-title":"Horm Res Paediatr"},{"issue":"13","key":"2180_CR15","doi-asserted-by":"publisher","first-page":"117955142095907","DOI":"10.1177\/1179551420959077","volume":"28","author":"A Al Shaikh","year":"2020","unstructured":"Al Shaikh A, Al Zahrani AM, Qari YH, et al. Quality of life in children with diabetes treated with insulin pump compared with multiple daily injections in tertiary care center. Clin Med Insights Endocrinol Diabetes. 2020;28(13):1179551420959077. https:\/\/doi.org\/10.1177\/1179551420959077.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"10","key":"2180_CR16","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/dc23-0635","volume":"46","author":"TSJ Crabtree","year":"2023","unstructured":"Crabtree TSJ, Griffin TP, Yap YW, et al. Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study. Diabetes Care. 2023;46(10):1831\u20138. https:\/\/doi.org\/10.2337\/dc23-0635.","journal-title":"Diabetes Care"},{"issue":"4","key":"2180_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/dme.13567","volume":"35","author":"C Farrington","year":"2018","unstructured":"Farrington C. Psychosocial impacts of hybrid close-loop systems in the management of diabetes: a review. Diabet Med. 2018;35(4):436\u201349. https:\/\/doi.org\/10.1111\/dme.13567.","journal-title":"Diabet Med"},{"issue":"3","key":"2180_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4239\/wjd.v15.i3.455","volume":"15","author":"A Eldib","year":"2024","unstructured":"Eldib A, Dhaver S, Kibaa K, et al. Evaluation of hybrid closed-loop insulin delivery system in type 1 diabetes in real-world clinical practice: one-year observational study. World J Diabetes. 2024;15(3):455\u201362. https:\/\/doi.org\/10.4239\/wjd.v15.i3.455.","journal-title":"World J Diabetes"},{"issue":"9","key":"2180_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/children11091085","volume":"11","author":"B Bombaci","year":"2024","unstructured":"Bombaci B, Torre A, Longo A, et al. Psychological and clinical challenges in the management of type 1 diabetes during adolescence: a narrative review. Child (Basel). 2024;11(9):1085. https:\/\/doi.org\/10.3390\/children11091085.","journal-title":"Child (Basel)"},{"issue":"3","key":"2180_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51(3):170\u20139. https:\/\/doi.org\/10.1136\/adc.51.3.170.","journal-title":"Arch Dis Child"},{"issue":"7","key":"2180_CR21","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pedi.13406","volume":"23","author":"N Glaser","year":"2022","unstructured":"Glaser N, Fritsch M, Priyambada L, et al. ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835\u201356. https:\/\/doi.org\/10.1111\/pedi.13406.","journal-title":"Pediatr Diabetes"},{"key":"2180_CR22","doi-asserted-by":"publisher","unstructured":"WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length\/height, weight and age. Acta Paediatr Suppl. 2006 Apr;450:76\u201385. https:\/\/doi.org\/10.1111\/j.1651-2227.2006.tb02378.x","DOI":"10.1111\/j.1651-2227.2006.tb02378.x"},{"issue":"8","key":"2180_CR23","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/dc08-1987","volume":"32","author":"HB Mortensen","year":"2009","unstructured":"Mortensen HB, Hougaard P, Swift P, et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care. 2009;32(8):1384\u201390. https:\/\/doi.org\/10.2337\/dc08-1987.","journal-title":"Diabetes Care"},{"key":"2180_CR24","doi-asserted-by":"publisher","unstructured":"De Bock M, Codner E, Craig ME, ISPAD Clinical Practice Consensus Guidelines. 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes 2022;23(8):1270-6. https:\/\/doi.org\/10.1111\/pedi.13455","DOI":"10.1111\/pedi.13455"},{"key":"2180_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1542\/peds.114.S2.555","volume":"114","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents","year":"2004","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555\u201376.","journal-title":"Pediatrics"},{"issue":"3","key":"2180_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629\u201337. https:\/\/doi.org\/10.1681\/ASN.2008030287.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2180_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.2337\/dc17-2707","volume":"41","author":"JW Varni","year":"2018","unstructured":"Varni JW, Delamater AM, Hood KK, et al. PedsQL 3.2 diabetes module for children, adolescent, and young adults: reliability and validity in type 1 diabetes. Diabetes Care. 2018;41(10):2064\u201371. https:\/\/doi.org\/10.2337\/dc17-2707.","journal-title":"Diabetes Care"},{"issue":"4","key":"2180_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/dia.2023.0510","volume":"26","author":"V Cherubini","year":"2024","unstructured":"Cherubini V, Zucchini S, Bonfanti R, Rabbone I, Scaramuzza A. Which treatment modalities are being used by Italian children and adolescents with type 1 diabetes? Diabetes Technol Ther. 2024;26(4):283\u201385. https:\/\/doi.org\/10.1089\/dia.2023.0510.","journal-title":"Diabetes Technol Ther"},{"key":"2180_CR29","doi-asserted-by":"publisher","first-page":"111621","DOI":"10.1016\/j.diabres.2024.111621","volume":"210","author":"V Cherubini","year":"2024","unstructured":"Cherubini V, Fargalli A, Arnaldi C, et al. Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: A multicenter real-world observational study. Diabetes Res Clin Pract. 2024;210:111621. https:\/\/doi.org\/10.1016\/j.diabres.2024.111621.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"2180_CR30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/jamapediatrics.2021.3965","volume":"175","author":"MB Abraham","year":"2021","unstructured":"Abraham MB, de Bock M, Smith GJ, et al. Effect of a hybrid closed-loop system on glycemic and psycosocial outcomes in children and adolescent with type 1 diabetes: a randomized clinical trial. JAMA Pediatr. 2021;175(12):1227\u201335. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.3965.","journal-title":"JAMA Pediatr"},{"issue":"11","key":"2180_CR31","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.2337\/dc22-0470","volume":"45","author":"B Matejko","year":"2022","unstructured":"Matejko B, Juza A, Kie\u0107-Wilk B, et al. Transitioning of people with type 1 diabetes from multiple daily injections and self-monitoring of blood glucose directly to MiniMed 780G advanced hybrid closed-loop system: a two-center, randomized, controlled study. Diabetes Care. 2022;45(11):2628\u201335. https:\/\/doi.org\/10.2337\/dc22-0470.","journal-title":"Diabetes Care"},{"issue":"7","key":"2180_CR32","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.numecd.2021.03.019","volume":"31","author":"P Di Bonito","year":"2021","unstructured":"Di Bonito P, Mozzillo E, Rosanio FM, et al. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic risk. Nutr Metab Cardiovasc Dis. 2021;31(7):2033\u201341. https:\/\/doi.org\/10.1016\/j.numecd.2021.03.019.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2180_CR33","doi-asserted-by":"publisher","unstructured":"Levey AS, Eckardt K-U, Dorman NM et al. Nomenclature for kidney function and disease: report of a kidney disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2020;97(6):1117-29. https:\/\/doi.org\/10.1016\/j.kint.2020.02.010","DOI":"10.1016\/j.kint.2020.02.010"},{"issue":"1","key":"2180_CR34","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1038\/s41598-024-54137-2","volume":"14","author":"YB Lin","year":"2024","unstructured":"Lin YB, Taiwan Diabetes Registry Study Group, Chang TJ. Age at onset of type 1 diabetes between puberty and 30 years old is associated with increased diabetic nephropathy risk. Sci Rep. 2024;14(1):3611. https:\/\/doi.org\/10.1038\/s41598-024-54137-2.","journal-title":"Sci Rep"},{"key":"2180_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/dmrr.520","volume":"21","author":"R Schiaffini","year":"2005","unstructured":"Schiaffini R, Ciampalini P, Spera S, et al. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes. Diabetes Metab Res Rev. 2005;21:347\u201352. https:\/\/doi.org\/10.1002\/dmrr.520.","journal-title":"Diabetes Metab Res Rev"},{"key":"2180_CR36","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1007\/s00125-013-3007-9","volume":"56","author":"SR Johnson","year":"2013","unstructured":"Johnson SR, Cooper MN, Jones TW, et al. Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study. Diabetologia. 2013;56:2392\u2013400. https:\/\/doi.org\/10.1007\/s00125-013-3007-9.","journal-title":"Diabetologia"},{"issue":"2","key":"2180_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1464-5491.2005.01738.x","volume":"23","author":"RPLM Hoogma","year":"2006","unstructured":"Hoogma RPLM, Hammond PJ, Gomis R, et al. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med. 2006;23(2):141\u201347. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01738.x.","journal-title":"Diabet Med"},{"key":"2180_CR38","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2147\/PPA.S206969","volume":"13","author":"K Dluzniak-Golaska","year":"2019","unstructured":"Dluzniak-Golaska K, Szostak-Wegierek D, Panczyk M, et al. May gender influence the quality of life in children and adolescent with type 1 diabetes? Patient Prefer Adherence. 2019;13:1589\u201397. https:\/\/doi.org\/10.2147\/PPA.S206969.","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"2180_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/s0277-9536(99)00340-8","volume":"50","author":"C Williams","year":"2000","unstructured":"Williams C. Doing health, doing gender: teenagers, diabetes and asthma. Soc Sci Med. 2000;50(3):387\u201396. https:\/\/doi.org\/10.1016\/s0277-9536(99)00340-8.","journal-title":"Soc Sci Med"},{"issue":"8","key":"2180_CR40","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2337\/dc16-1990","volume":"40","author":"BJ Anderson","year":"2017","unstructured":"Anderson BJ, Laffel LM, Domenger C, et al. Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: The Global TEENs Study. Diabetes Care. 2017;40(8):1002\u20139. https:\/\/doi.org\/10.2337\/dc16-1990.","journal-title":"Diabetes Care"},{"issue":"1","key":"2180_CR41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pec.2012.10.014","volume":"91","author":"ME Hilliard","year":"2013","unstructured":"Hilliard ME, Mann KA, Peugh JL, et al. How poorer quality of life in adolescence predicts subsequent type 1 diabetes management and control. Patient Educ Couns. 2013;91(1):120\u20135. https:\/\/doi.org\/10.1016\/j.pec.2012.10.014.","journal-title":"Patient Educ Couns"},{"issue":"3","key":"2180_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2337\/diacare.26.3.631","volume":"26","author":"JW Varni","year":"2003","unstructured":"Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL in type 1 and type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care. 2003;26(3):631\u201337. https:\/\/doi.org\/10.2337\/diacare.26.3.631.","journal-title":"Diabetes Care"},{"key":"2180_CR43","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3389\/fped.2019.00566","volume":"7","author":"KI Fischer","year":"2020","unstructured":"Fischer KI, Fischer FH, Barthel D, et al. Trajectories of Health-Related Quality of life and HbA1c values of children and adolescents with diabetes mellitus type 1 over 6 months: a longitudinal observational study. Front Pediatr. 2020;7:566. https:\/\/doi.org\/10.3389\/fped.2019.00566.","journal-title":"Front Pediatr"},{"issue":"4","key":"2180_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1159\/000347052","volume":"22","author":"M Abdul-Rasoul","year":"2013","unstructured":"Abdul-Rasoul M, AlOtaibi F, Abdulla A, Rahme Z, AlShawaf F. Quality of life of children and adolescents with type 1 diabetes in Kuwait. Med Princ Pract. 2013;22(4):379\u201384. https:\/\/doi.org\/10.1159\/000347052.","journal-title":"Med Princ Pract"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02180-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02180-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:03:37Z","timestamp":1783605817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02180-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2180"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02180-6","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,17]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Comitato Unico Regionale Friuli Venezia Giulia (CEUR-2018-Em-323-Burlo). Written informed consent was obtained from all participants and, in the case of minors, from their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}